BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?”
We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.
Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY. He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA. During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.
What is most rewarding to you as you consider your contribution to clinical trial research?
It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.
A quick honest moment here: I haven’t always liked writing blog posts. When I first started writing, I informed the BBK social media team that I simply was not a fan of this kind of expression. Nonetheless, they pushed me. Their guidance included quick and easy guidelines for blog writing. The advice of the social media team transformed my resistance to enthusiasm and now, I surprisingly enjoy expressing my opinions and thoughts through this medium.
So, you may be asking, what’s the point to this personal introduction?
Enrollment goals – every site has them. As the study sponsor, you’ve made your projections and communicated your expectations to each principal investigator. They have all assured you that they’ll have no trouble meeting your goals. Perhaps even a few of them told you they can enroll more than your goal. No problem, right?
It’s a common practice in our industry (at least from my vantage point) to hear talk of the screen failure “rate” of any given study.
BBK Worldwide announced today an expanded suite of products that streamlines retention efforts at the site level. Among these products are the Ready. Set. Go.℠ Card (RSG℠ Card), Ready. Set. Go.℠ Ride (RSG℠ Ride), and Ready. Set. Go.℠ Minder (RSG℠ Minder). These products are customized for today’s clinical research coordinator who is tasked with multiple responsibilities and demands. Through the efficiencies these products create, the clinical research coordinator is allowed to focus his or her efforts on other study-related priorities.
During my last blog, I talked about the increasing demand for contact centers for patient recruitment due to their enhanced capabilities over the past decade. Today, I’d like to share with you some specific advantages of a well-trained, recruitment-focused contact center team.